Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study-Reference-Cited by-同舟云学术

Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study

Published:2014-06-19 Issue:25 Volume:123 Page:3972-3978
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Chee Cheng E.¹^ORCID,Ashrani Aneel A.²^ORCID,Marks Randolph S.³,Petterson Tanya M.⁴,Bailey Kent R.⁴,Melton L. Joseph⁵,Heit John A.²⁵⁶^ORCID

Affiliation:

1. Division of Hematology and Oncology, Department of Medicine, Case Western Reserve University, Cleveland, OH; and

2. Division of Hematology, Department of Internal Medicine,

3. Division of Medical Oncology, Department of Oncology,

4. Division of Biomedical Statistics and Informatics, Department of Health Sciences Research,

5. Division of Epidemiology, Department of Health Sciences Research, and

6. Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, MN

Abstract

Key Points VTE recurrence risk in patients with cancer can be stratified by cancer type, stage, stage progression, and presence of leg paresis. Patients with cancer at high VTE recurrence risk should be considered for secondary prophylaxis.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/123/25/3972/1464687/3972.pdf

Reference41 articles.

1. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study.;Heit;Arch Intern Med,2000

2. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis.;Hutten;J Clin Oncol,2000

3. Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors.;Hansson;Arch Intern Med,2000

4. Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy.;Douketis;Arch Intern Med,2000

5. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.;Prandoni;Blood,2002

Cited by 168 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk Factors for Bleeding Events in Japanese Patients with Advanced Lung Cancer: Data from the Rising-VTE/NEJ037 Study;Cancers;2024-01-10

2. Incidence of venous thromboembolism and association with PD-L1 expression in advanced non-small cell lung cancer patients treated with first-line chemo-immunotherapy;Frontiers in Oncology;2024-01-08

3. Anticoagulant treatment of cancer-associated thromboembolism;Archives of Cardiovascular Diseases;2024-01

4. Impact of venous thromboembolism on the mortality in patients with cancer: a population-based cohort study;The Lancet Regional Health - Europe;2023-11

5. Risk of recurrent cancer-associated venous thromboembolism: A Danish nationwide cohort study;International Journal of Cardiology;2023-11